Deletion of pyruvate dehydrogenase kinases reduces susceptibility to deep vein thrombosis in mice.

Gagan D Flora, Madankumar Ghatge, Manasa K Nayak, Tarun Barbhuyan, Mariia Kumskova, Anil K Chauhan
Author Information
  1. Gagan D Flora: Division of Hematology/Oncology, Department of Internal Medicine, University of Iowa, Iowa City, IA. ORCID
  2. Madankumar Ghatge: Division of Hematology/Oncology, Department of Internal Medicine, University of Iowa, Iowa City, IA. ORCID
  3. Manasa K Nayak: Division of Hematology/Oncology, Department of Internal Medicine, University of Iowa, Iowa City, IA. ORCID
  4. Tarun Barbhuyan: Division of Hematology/Oncology, Department of Internal Medicine, University of Iowa, Iowa City, IA. ORCID
  5. Mariia Kumskova: Division of Hematology/Oncology, Department of Internal Medicine, University of Iowa, Iowa City, IA. ORCID
  6. Anil K Chauhan: Division of Hematology/Oncology, Department of Internal Medicine, University of Iowa, Iowa City, IA. ORCID

Abstract

ABSTRACT: Neutrophils contribute to deep vein thrombosis (DVT) by releasing prothrombotic neutrophil extracellular traps (NETs). NET formation (known as NETosis) is an energy-intensive process that requires an increased rate of aerobic glycolysis. The metabolic enzymes pyruvate dehydrogenase kinases (PDKs) inhibit the pyruvate dehydrogenase complex to divert the pyruvate flux from oxidative phosphorylation toward aerobic glycolysis. Herein, we identified that the combined deletion of PDK2 and PDK4 (PDK2/4-/-) renders mice less susceptible to DVT (measured by thrombus incidence, weight, and length) in the inferior vena cava-stenosis model at day 2 after surgery. Compared with wild-type (WT) mice, the venous thrombus obtained from PDK2/4-/- mice exhibited reduced citrullinated histone content, a known marker of NETs. In line with in vivo observations, phorbol 12-myristate 13-acetate (PMA)-stimulated PDK2/4-/- neutrophils displayed reduced NETosis and secretion of cathepsin G and elastase compared with PMA-stimulated WT neutrophils. The formation of platelet aggregates mediated by PMA-stimulated PDK2/4-/- neutrophils were significantly reduced compared with PMA-stimulated WT neutrophils. Finally, PDK2/4-/- neutrophils exhibited reduced levels of intracellular Ca2+ concentration, extracellular signal-regulated kinase 1/2 (Erk1/2) phosphorylation, and glycolytic proton efflux rate (a measure of aerobic glycolysis), known to facilitate NETosis. Together, these findings elucidate, to our knowledge, for the first time, the fundamental role of PDK2/4 in regulating NETosis and acute DVT.

References

  1. Blood. 2014 May 1;123(18):2768-76 [PMID: 24366358]
  2. Lancet. 2017 Dec 17;388(10063):3060-3073 [PMID: 27375038]
  3. Blood. 2017 Mar 9;129(10):1357-1367 [PMID: 28073784]
  4. Elife. 2017 Jun 02;6: [PMID: 28574339]
  5. Blood. 2021 Mar 25;137(12):1658-1668 [PMID: 33027814]
  6. Biochim Biophys Acta. 1987 Mar 11;927(3):429-36 [PMID: 3101746]
  7. Trends Immunol. 2018 Aug;39(8):610-623 [PMID: 29776849]
  8. Blood Adv. 2023 Jun 13;7(11):2347-2359 [PMID: 36971790]
  9. Int J Biochem Cell Biol. 2020 Nov;128:105850 [PMID: 32950686]
  10. Microcirculation. 2020 Aug;27(6):e12620 [PMID: 32279379]
  11. Biochim Biophys Acta Mol Basis Dis. 2019 Dec 1;1865(12):165542 [PMID: 31473341]
  12. Blood Adv. 2018 Aug 14;2(15):2029-2038 [PMID: 30108111]
  13. J Biol Chem. 2014 Jun 13;289(24):16615-23 [PMID: 24798336]
  14. Nutr Metab (Lond). 2014 Feb 12;11(1):10 [PMID: 24520982]
  15. Science. 2001 Apr 20;292(5516):504-7 [PMID: 11283355]
  16. Thromb Res. 2011 May;127(5):478-86 [PMID: 21296387]
  17. Cureus. 2021 Oct 23;13(10):e18992 [PMID: 34853735]
  18. J Thromb Haemost. 2021 Mar;19(3):814-821 [PMID: 33300307]
  19. Immunol Rev. 2023 Mar;314(1):427-441 [PMID: 36326284]
  20. J Leukoc Biol. 2020 Feb;107(2):285-297 [PMID: 31841231]
  21. Life Sci. 2019 Mar 15;221:178-186 [PMID: 30771312]
  22. Arterioscler Thromb Vasc Biol. 2019 Mar;39(3):331-338 [PMID: 30700128]
  23. Thromb Res. 2018 Oct;170:87-96 [PMID: 30138777]
  24. Cardiovasc Res. 2023 Nov 25;119(15):2497-2507 [PMID: 37706546]
  25. J Neurosci Res. 2016 Sep;94(9):837-49 [PMID: 26931482]
  26. J Thromb Haemost. 2023 Aug;21(8):2163-2174 [PMID: 37061131]
  27. Nat Chem Biol. 2011 Feb;7(2):75-7 [PMID: 21170021]
  28. Front Cardiovasc Med. 2022 Jan 31;8:824112 [PMID: 35174225]
  29. Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):1777-83 [PMID: 22652600]
  30. Front Cardiovasc Med. 2019 Jun 20;6:85 [PMID: 31281822]
  31. Arterioscler Thromb Vasc Biol. 2019 Sep;39(9):1724-1738 [PMID: 31315434]
  32. Stroke. 2023 Sep;54(9):2409-2419 [PMID: 37449422]

Grants

  1. R01 NS109910/NINDS NIH HHS
  2. R35 HL139926/NHLBI NIH HHS
  3. U01 NS130587/NINDS NIH HHS

MeSH Term

Animals
Venous Thrombosis
Mice
Pyruvate Dehydrogenase Acetyl-Transferring Kinase
Neutrophils
Mice, Knockout
Disease Models, Animal
Extracellular Traps
Disease Susceptibility
Gene Deletion

Chemicals

Pyruvate Dehydrogenase Acetyl-Transferring Kinase
Pdk4 protein, mouse
Pdk2 protein, mouse